menu search

ETON / Eton Pharma Shares Tick Higher After Offloading Hospital Products

Eton Pharma Shares Tick Higher After Offloading Hospital Products
Eton Pharmaceuticals Inc (NASDAQ: ETON) has sold its hospital products to Dr. Reddy's Laboratories SA, a subsidiary of Dr. Reddy's Laboratories Ltd (NYSE: RDY), for $50 million. "The sale of our hospital products allows us to focus our resources on our core. Read More
Posted: Jun 24 2022, 09:51
Author Name: Benzinga
Views: 102230

ETON News  

Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

By GlobeNewsWire
October 30, 2023

Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

DEER PARK, Ill., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developi more_horizontal

Here's Why 'Trend' Investors Would Love Betting on Eton Pharmaceuticals, Inc. (ETON)

By Zacks Investment Research
September 12, 2023

Here's Why 'Trend' Investors Would Love Betting on Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals, Inc. (ETON) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently o more_horizontal

Eton Pharmaceuticals: Fading The Rally

By Seeking Alpha
September 11, 2023

Eton Pharmaceuticals: Fading The Rally

Eton Pharmaceuticals, Inc. is a small specialty pharmaceutical company whose main product ALKINDI SPRINKLE is gaining market share. The stock has doub more_horizontal

Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

By GlobeNewsWire
August 23, 2023

Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

DEER PARK, Ill., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developin more_horizontal

Eton Pharmaceuticals, Inc. (ETON) Hits Fresh High: Is There Still Room to Run?

By Zacks Investment Research
August 16, 2023

Eton Pharmaceuticals, Inc. (ETON) Hits Fresh High: Is There Still Room to Run?

Eton Pharmaceuticals, Inc. (ETON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundament more_horizontal

Why Is Eton Pharmaceuticals (ETON) Stock Up 30% Today?

By InvestorPlace
August 11, 2023

Why Is Eton Pharmaceuticals (ETON) Stock Up 30% Today?

Eton Pharmaceuticals (NASDAQ: ETON ) stock is soaring following the release of its earnings report for the second quarter of 2023! The big new exciti more_horizontal

Eton Pharmaceuticals, Inc. (ETON) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 10, 2023

Eton Pharmaceuticals, Inc. (ETON) Q2 2023 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants David Krempa - Chief Busine more_horizontal

Eton Pharmaceuticals, Inc. (ETON) Tops Q2 Earnings and Revenue Estimates

By Zacks Investment Research
August 10, 2023

Eton Pharmaceuticals, Inc. (ETON) Tops Q2 Earnings and Revenue Estimates

Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of a loss of $0.09 per sha more_horizontal


Search within

Pages Search Results: